Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Several drug classes are known to be associated with serious upper gastrointestinal bleeding (UGIB), among others NSAID, low-dose acetylsalicylic acid (ASA), vitamin K antagonists (VKA), clopidogrel and selective serotonin reuptake inhibitors (SSRIs). There are few data on how and to what extent these drugs are reintroduced in patients who have been discharged after a bleeding episode related to any of them.
OriginalsprogEngelsk
TidsskriftAlimentary Pharmacology and Therapeutics
Vol/bind35
Udgave nummer8
Sider (fra-til)948-54
Antal sider7
ISSN0269-2813
DOI
StatusUdgivet - 2012

Fingeraftryk

clopidogrel
Serotonin Uptake Inhibitors
Pharmaceutical Preparations

Citer dette

@article{a0727258e1c74c4da5097b8959e6c104,
title = "Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding",
abstract = "Several drug classes are known to be associated with serious upper gastrointestinal bleeding (UGIB), among others NSAID, low-dose acetylsalicylic acid (ASA), vitamin K antagonists (VKA), clopidogrel and selective serotonin reuptake inhibitors (SSRIs). There are few data on how and to what extent these drugs are reintroduced in patients who have been discharged after a bleeding episode related to any of them.",
keywords = "Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Case-Control Studies, Drug Prescriptions, Drug Therapy, Combination, Gastrointestinal Hemorrhage, Hematologic Agents, Humans, Middle Aged, Patient Discharge, Pharmaceutical Preparations, Physician's Practice Patterns, Proton Pump Inhibitors, Risk Factors, Serotonin Uptake Inhibitors, Time Factors, Vitamin K",
author = "M Dall and Christensen, {Ren{\'e} dePont} and {Schaffalitzky de Muckadell}, {O B} and Lassen, {A T} and Jesper Hallas",
note = "{\circledC} 2012 Blackwell Publishing Ltd.",
year = "2012",
doi = "10.1111/j.1365-2036.2012.05006.x",
language = "English",
volume = "35",
pages = "948--54",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding

AU - Dall, M

AU - Christensen, René dePont

AU - Schaffalitzky de Muckadell, O B

AU - Lassen, A T

AU - Hallas, Jesper

N1 - © 2012 Blackwell Publishing Ltd.

PY - 2012

Y1 - 2012

N2 - Several drug classes are known to be associated with serious upper gastrointestinal bleeding (UGIB), among others NSAID, low-dose acetylsalicylic acid (ASA), vitamin K antagonists (VKA), clopidogrel and selective serotonin reuptake inhibitors (SSRIs). There are few data on how and to what extent these drugs are reintroduced in patients who have been discharged after a bleeding episode related to any of them.

AB - Several drug classes are known to be associated with serious upper gastrointestinal bleeding (UGIB), among others NSAID, low-dose acetylsalicylic acid (ASA), vitamin K antagonists (VKA), clopidogrel and selective serotonin reuptake inhibitors (SSRIs). There are few data on how and to what extent these drugs are reintroduced in patients who have been discharged after a bleeding episode related to any of them.

KW - Aged

KW - Aged, 80 and over

KW - Anti-Inflammatory Agents, Non-Steroidal

KW - Case-Control Studies

KW - Drug Prescriptions

KW - Drug Therapy, Combination

KW - Gastrointestinal Hemorrhage

KW - Hematologic Agents

KW - Humans

KW - Middle Aged

KW - Patient Discharge

KW - Pharmaceutical Preparations

KW - Physician's Practice Patterns

KW - Proton Pump Inhibitors

KW - Risk Factors

KW - Serotonin Uptake Inhibitors

KW - Time Factors

KW - Vitamin K

U2 - 10.1111/j.1365-2036.2012.05006.x

DO - 10.1111/j.1365-2036.2012.05006.x

M3 - Journal article

C2 - 22313346

VL - 35

SP - 948

EP - 954

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 8

ER -